<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/css" href="http://owiki.kmu.edu.tw/skins/common/feed.css?63"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="zh-tw">
		<id>http://owiki.kmu.edu.tw/index.php?action=history&amp;feed=atom&amp;title=Syndrome</id>
		<title>Syndrome - 修訂歷史</title>
		<link rel="self" type="application/atom+xml" href="http://owiki.kmu.edu.tw/index.php?action=history&amp;feed=atom&amp;title=Syndrome"/>
		<link rel="alternate" type="text/html" href="http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;action=history"/>
		<updated>2026-04-04T03:07:50Z</updated>
		<subtitle>本站上此頁的修訂歷史</subtitle>
		<generator>MediaWiki 1.10.1</generator>

	<entry>
		<id>http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24625&amp;oldid=prev</id>
		<title>Guhjy在2018年3月29日 (四) 09:15</title>
		<link rel="alternate" type="text/html" href="http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24625&amp;oldid=prev"/>
				<updated>2018-03-29T09:15:40Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月29日 (四) 09:15所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第22行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第22行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Renal tubule defects:&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Renal tubule defects:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Electrolyte and acid-base dis., polyuria, nocturia, renal transport defects, renal calcification or stone, normal-sized kidneys; hematuria, proteinuria (usually &amp;lt;1 g/24 hours), nocturia, bone pain, rickets&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Electrolyte and acid-base dis., polyuria, nocturia, renal transport defects, renal calcification or stone, normal-sized kidneys; hematuria, proteinuria (usually &amp;lt;1 g/24 hours), nocturia, bone pain, rickets&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Glomerular vascular syndrome: HT, proteinuria, hematuria&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Glomerular vascular syndrome: HT, proteinuria, hematuria&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Pulmonary-renal syndrome:&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Pulmonary-renal syndrome:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Catastrophic hemoptysis (lung infiltrate) + GN (esp. RPGN)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Catastrophic hemoptysis (lung infiltrate) + GN (esp. RPGN)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Urinary tract infection (UTI):&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Urinary tract infection (UTI):&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**Fever, dysuria, frequency, urgency, suprapubic pain, flank pain, pyuria (WBC &amp;amp;ge; 2-5/HPF of mid-stream urine), bacteriuria (&amp;amp;ge; &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;102 &lt;/del&gt;single flora colonies/mL if symptomatic or catheterized; &amp;amp;ge; &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;105 &lt;/del&gt;single flora colonies/mL x 1 [men]~2 [women] if asymptomatic), bacteria in unspun urine, WBC casts&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Fever, dysuria, frequency, urgency, suprapubic pain, flank pain, pyuria (WBC &amp;amp;ge; 2-5/HPF of mid-stream urine), bacteriuria (&amp;amp;ge; &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;10&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt; &lt;/ins&gt;single flora colonies/mL if symptomatic or catheterized; &amp;amp;ge; &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;10&amp;lt;sup&amp;gt;5&amp;lt;/sup&amp;gt; &lt;/ins&gt;single flora colonies/mL x 1 [men]~2 [women] if asymptomatic), bacteria in unspun urine, WBC casts&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**1. Uncomplicated, 2. Complicated&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**1. Uncomplicated, 2. Complicated&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**1. Cystitis, 2. prostatitis, 3. pyelonephritis 4. renal abscess, 5. catheter-related UTI, 6. asymptomatic bacteriuria (do not treat unless pregnant), (7. urethritis)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**1. Cystitis, 2. prostatitis, 3. pyelonephritis 4. renal abscess, 5. catheter-related UTI, 6. asymptomatic bacteriuria (do not treat unless pregnant), (7. urethritis)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Urinary tract obstruction: Oliguria, nocturia, slowing of micturition, BPH, hydronephrosis, flank pain, full bladder ppost-voiding; hematuria, pyuria, enuresis, dysuria, HT, urinary retention,, azotemia, AKI, CKD&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Urinary tract obstruction: Oliguria, nocturia, slowing of micturition, BPH, hydronephrosis, flank pain, full bladder ppost-voiding; hematuria, pyuria, enuresis, dysuria, HT, urinary retention,, azotemia, AKI, CKD&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Cardiorenal syndrome: type 1 (acute), type 2 (chronic), type 3 (acute renocardiac), type 4 (chronic renocardiac), type 5 (systemic dis.)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Cardiorenal syndrome: type 1 (acute), type 2 (chronic), type 3 (acute renocardiac), type 4 (chronic renocardiac), type 5 (systemic dis.)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Guhjy</name></author>	</entry>

	<entry>
		<id>http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24624&amp;oldid=prev</id>
		<title>Guhjy在2018年3月29日 (四) 09:14</title>
		<link rel="alternate" type="text/html" href="http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24624&amp;oldid=prev"/>
				<updated>2018-03-29T09:14:46Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月29日 (四) 09:14所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第22行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第22行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Renal tubule defects:&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Renal tubule defects:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Electrolyte and acid-base dis., polyuria, nocturia, renal transport defects, renal calcification or stone, normal-sized kidneys; hematuria, proteinuria (usually &amp;lt;1 g/24 hours), nocturia, bone pain, rickets&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Electrolyte and acid-base dis., polyuria, nocturia, renal transport defects, renal calcification or stone, normal-sized kidneys; hematuria, proteinuria (usually &amp;lt;1 g/24 hours), nocturia, bone pain, rickets&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*Glomerular vascular syndrome: HT, proteinuria, hematuria&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*Pulmonary-renal syndrome:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Catastrophic hemoptysis (lung infiltrate) + GN (esp. RPGN)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*Urinary tract infection (UTI):&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Fever, dysuria, frequency, urgency, suprapubic pain, flank pain, pyuria (WBC &amp;amp;ge; 2-5/HPF of mid-stream urine), bacteriuria (&amp;amp;ge; 102 single flora colonies/mL if symptomatic or catheterized; &amp;amp;ge; 105 single flora colonies/mL x 1 [men]~2 [women] if asymptomatic), bacteria in unspun urine, WBC casts&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**1. Uncomplicated, 2. Complicated&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**1. Cystitis, 2. prostatitis, 3. pyelonephritis 4. renal abscess, 5. catheter-related UTI, 6. asymptomatic bacteriuria (do not treat unless pregnant), (7. urethritis)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*Urinary tract obstruction: Oliguria, nocturia, slowing of micturition, BPH, hydronephrosis, flank pain, full bladder ppost-voiding; hematuria, pyuria, enuresis, dysuria, HT, urinary retention,, azotemia, AKI, CKD&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;*Cardiorenal syndrome: type 1 (acute), type 2 (chronic), type 3 (acute renocardiac), type 4 (chronic renocardiac), type 5 (systemic dis.)&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Guhjy</name></author>	</entry>

	<entry>
		<id>http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24623&amp;oldid=prev</id>
		<title>Guhjy在2018年3月29日 (四) 09:12</title>
		<link rel="alternate" type="text/html" href="http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24623&amp;oldid=prev"/>
				<updated>2018-03-29T09:12:09Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月29日 (四) 09:12所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第13行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第13行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Hematuria/proteinuria ± HT &amp;gt;3 months&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Hematuria/proteinuria ± HT &amp;gt;3 months&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Nephrotic syndrome (NS):&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Nephrotic syndrome (NS):&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**Proteinuria &amp;gt;3.5 g/1.73 &lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;m2&lt;/del&gt;/day; hypoalbuminemia, hyperlipidemia (esp. hypercholesterolemia), casts, lipiduria, edema&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Proteinuria &amp;gt;3.5 g/1.73 &lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;m&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt;&lt;/ins&gt;/day; hypoalbuminemia, hyperlipidemia (esp. hypercholesterolemia), casts, lipiduria, edema&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Chronic kidney disease (CKD):&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Chronic kidney disease (CKD):&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Stage 1-5 (eGFR &amp;lt; 60 mL/min/1.73 m&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt; or proteinuria), &amp;gt; 3 months.&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Stage 1-5 (eGFR &amp;lt; 60 mL/min/1.73 m&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt; or proteinuria), &amp;gt; 3 months.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Guhjy</name></author>	</entry>

	<entry>
		<id>http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24622&amp;oldid=prev</id>
		<title>Guhjy在2018年3月29日 (四) 09:11</title>
		<link rel="alternate" type="text/html" href="http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24622&amp;oldid=prev"/>
				<updated>2018-03-29T09:11:40Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月29日 (四) 09:11所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第15行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第15行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Proteinuria &amp;gt;3.5 g/1.73 m2/day; hypoalbuminemia, hyperlipidemia (esp. hypercholesterolemia), casts, lipiduria, edema&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Proteinuria &amp;gt;3.5 g/1.73 m2/day; hypoalbuminemia, hyperlipidemia (esp. hypercholesterolemia), casts, lipiduria, edema&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Chronic kidney disease (CKD):&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Chronic kidney disease (CKD):&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;**Stage 1-5 (eGFR &amp;lt; 60 mL/min/1.&lt;del style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;73m&amp;amp;sup2 &lt;/del&gt;or proteinuria), &amp;gt; 3 months.&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;**Stage 1-5 (eGFR &amp;lt; 60 mL/min/1.&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;73 m&amp;lt;sup&amp;gt;2&amp;lt;/sup&amp;gt; &lt;/ins&gt;or proteinuria), &amp;gt; 3 months.&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Chronic renal failure (CRF): &lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Chronic renal failure (CRF): &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Azotemia&amp;gt;3 months; urine broad waxy casts (“renal failure casts”), uremic symptoms, proteinuria, hematuria, urine casts, nocturia, HT, edema, acid-base/electrolyte dis.&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;**Azotemia&amp;gt;3 months; urine broad waxy casts (“renal failure casts”), uremic symptoms, proteinuria, hematuria, urine casts, nocturia, HT, edema, acid-base/electrolyte dis.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Guhjy</name></author>	</entry>

	<entry>
		<id>http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24621&amp;oldid=prev</id>
		<title>Guhjy在2018年3月29日 (四) 09:10</title>
		<link rel="alternate" type="text/html" href="http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24621&amp;oldid=prev"/>
				<updated>2018-03-29T09:10:47Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;

			&lt;table border='0' width='98%' cellpadding='0' cellspacing='4' style=&quot;background-color: white;&quot;&gt;
			&lt;tr&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;←上一修訂&lt;/td&gt;
				&lt;td colspan='2' width='50%' align='center' style=&quot;background-color: white;&quot;&gt;在2018年3月29日 (四) 09:10所做的修訂版本&lt;/td&gt;
			&lt;/tr&gt;
		&lt;tr&gt;&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第1行：&lt;/strong&gt;&lt;/td&gt;
&lt;td colspan=&quot;2&quot; align=&quot;left&quot;&gt;&lt;strong&gt;第1行：&lt;/strong&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Asymptomatic urinary abnormalities:&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Asymptomatic urinary abnormalities:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*Asymptomatic hematuria/proteinuria, pyuria, casts, crystals&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*&lt;/ins&gt;*Asymptomatic hematuria/proteinuria, pyuria, casts, crystals&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Acute nephritic syndrome (aGN): &lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Acute nephritic syndrome (aGN): &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*Hematuria (± RBC casts), (mild to moderate) proteinuria, pyuria, azotemia (GFR &amp;amp;darr;) in days, HT, edema, oliguria, sometimes causes RPGN&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*&lt;/ins&gt;*Hematuria (± RBC casts), (mild to moderate) proteinuria, pyuria, azotemia (GFR &amp;amp;darr;) in days, HT, edema, oliguria, sometimes causes RPGN&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Rapidly progressive GN (RPGN): &lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Rapidly progressive GN (RPGN): &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*aGN with azotemia in weeks~3  months (subacute renal failure), oliguria, HT, edema, hematuria, proteinuria, pyuria, casts&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*&lt;/ins&gt;*aGN with azotemia in weeks~3  months (subacute renal failure), oliguria, HT, edema, hematuria, proteinuria, pyuria, casts&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*Usually crescentic GN (&amp;gt;50% glomeruli with crescents)&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*&lt;/ins&gt;*Usually crescentic GN (&amp;gt;50% glomeruli with crescents)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Acute renal failure (ARF) or acute kidney injury (AKI): &lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Acute renal failure (ARF) or acute kidney injury (AKI): &lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*Azotemia in days; oliguric or non-oliguric, hypertension, edema&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*&lt;/ins&gt;*Azotemia in days; oliguric or non-oliguric, hypertension, edema&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Basement membrane syndrome&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*Basement membrane syndrome&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*Hematuria, proteinuria, renal failure&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*&lt;/ins&gt;*Hematuria, proteinuria, renal failure&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*(Chronic GN: a poorly defined entity)&lt;/td&gt;&lt;td&gt; &lt;/td&gt;&lt;td style=&quot;background: #eee; font-size: smaller;&quot;&gt;*(Chronic GN: a poorly defined entity)&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td&gt;-&lt;/td&gt;&lt;td style=&quot;background: #ffa; font-size: smaller;&quot;&gt;*Hematuria/proteinuria ± HT &amp;gt;3 months&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*&lt;/ins&gt;*Hematuria/proteinuria ± HT &amp;gt;3 months&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*Nephrotic syndrome (NS):&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;**Proteinuria &amp;gt;3.5 g/1.73 m2/day; hypoalbuminemia, hyperlipidemia (esp. hypercholesterolemia), casts, lipiduria, edema&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*Chronic kidney disease (CKD):&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;**Stage 1-5 (eGFR &amp;lt; 60 mL/min/1.73m&amp;amp;sup2 or proteinuria), &amp;gt; 3 months.&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*Chronic renal failure (CRF): &lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;**Azotemia&amp;gt;3 months; urine broad waxy casts (“renal failure casts”), uremic symptoms, proteinuria, hematuria, urine casts, nocturia, HT, edema, acid-base/electrolyte dis.&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*Uremia (acute or chronic): Azotemia + uremic syndrome&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*ESRD (end-stage renal disease): CKD stage 5D or chronic dialysis&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;*Renal tubule defects:&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;nbsp;&lt;/td&gt;&lt;td&gt;+&lt;/td&gt;&lt;td style=&quot;background: #cfc; font-size: smaller;&quot;&gt;&lt;ins style=&quot;color: red; font-weight: bold; text-decoration: none;&quot;&gt;**Electrolyte and acid-base dis., polyuria, nocturia, renal transport defects, renal calcification or stone, normal-sized kidneys; hematuria, proteinuria (usually &amp;lt;1 g/24 hours), nocturia, bone pain, rickets&lt;/ins&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Guhjy</name></author>	</entry>

	<entry>
		<id>http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24620&amp;oldid=prev</id>
		<title>Guhjy: 新頁面: *Asymptomatic urinary abnormalities: *Asymptomatic hematuria/proteinuria, pyuria, casts, crystals *Acute nephritic syndrome (aGN):  *Hematuria (± RBC casts), (mild to moderate) proteinur...</title>
		<link rel="alternate" type="text/html" href="http://owiki.kmu.edu.tw/index.php?title=Syndrome&amp;diff=24620&amp;oldid=prev"/>
				<updated>2018-03-29T09:07:46Z</updated>
		
		<summary type="html">&lt;p&gt;新頁面: *Asymptomatic urinary abnormalities: *Asymptomatic hematuria/proteinuria, pyuria, casts, crystals *Acute nephritic syndrome (aGN):  *Hematuria (± RBC casts), (mild to moderate) proteinur...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新頁面&lt;/b&gt;&lt;/p&gt;&lt;div&gt;*Asymptomatic urinary abnormalities:&lt;br /&gt;
*Asymptomatic hematuria/proteinuria, pyuria, casts, crystals&lt;br /&gt;
*Acute nephritic syndrome (aGN): &lt;br /&gt;
*Hematuria (± RBC casts), (mild to moderate) proteinuria, pyuria, azotemia (GFR &amp;amp;darr;) in days, HT, edema, oliguria, sometimes causes RPGN&lt;br /&gt;
*Rapidly progressive GN (RPGN): &lt;br /&gt;
*aGN with azotemia in weeks~3  months (subacute renal failure), oliguria, HT, edema, hematuria, proteinuria, pyuria, casts&lt;br /&gt;
*Usually crescentic GN (&amp;gt;50% glomeruli with crescents)&lt;br /&gt;
*Acute renal failure (ARF) or acute kidney injury (AKI): &lt;br /&gt;
*Azotemia in days; oliguric or non-oliguric, hypertension, edema&lt;br /&gt;
*Basement membrane syndrome&lt;br /&gt;
*Hematuria, proteinuria, renal failure&lt;br /&gt;
*(Chronic GN: a poorly defined entity)&lt;br /&gt;
*Hematuria/proteinuria ± HT &amp;gt;3 months&lt;/div&gt;</summary>
		<author><name>Guhjy</name></author>	</entry>

	</feed>